phenformin has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jaidee, R; Kongpetch, S; Kukongviriyapan, U; Kukongviriyapan, V; Prawan, A; Senggunprai, L | 1 |
| Chang, JH; Choi, J; Kang, JH; Kang, SG; Kim, SY; Park, J; Shim, JK | 1 |
| Albini, A; Argenziano, G; Ciarrocchi, A; Dallaglio, K; Dominici, M; Grisendi, G; Longo, C; Petrachi, T; Romagnani, A | 1 |
3 other study(ies) available for phenformin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Culture Media, Conditioned; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasm Invasiveness; Neovascularization, Physiologic; Oxidative Stress; Phenformin; Phosphorylation; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2020 |
Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.
Topics: Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Biomarkers, Tumor; Brain Neoplasms; Cell Proliferation; Contraceptive Agents, Male; Electron Transport Complex I; Energy Metabolism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Gossypol; Humans; Hypoglycemic Agents; Male; Mice; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Neoplastic Stem Cells; Oxidative Phosphorylation; Phenformin; Prognosis; Survival Rate; Xenograft Model Antitumor Assays | 2018 |
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Topics: Aldehyde Dehydrogenase; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Metformin; Microphthalmia-Associated Transcription Factor; Neoplasm Invasiveness; Neoplastic Stem Cells; Phenformin; Phenotype; Skin Neoplasms; Spheroids, Cellular; Time Factors; Transfection | 2017 |